GLG Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | $2.29M | Buy |
26,933
+6,816
| +34% | +$579K | 0.11% | 209 |
|
|
2017
Q3 | $1.74M | Buy |
+20,117
| New | +$1.74M | 0.09% | 196 |
|
|
2017
Q1 | – | Sell |
-5,076
| Closed | -$300K | – | 509 |
|
|
2016
Q4 | $300K | Sell |
5,076
-100,920
| -95% | -$5.96M | 0.01% | 317 |
|
|
2016
Q3 | $7.03M | Sell |
105,996
-88,394
| -45% | -$5.86M | 0.22% | 114 |
|
|
2016
Q2 | $10.5M | Buy |
194,390
+189,762
| +4,100% | +$10.3M | 0.31% | 82 |
|
|
2016
Q1 | $239K | Buy |
+4,628
| New | +$239K | 0.01% | 342 |
|